Skip to content

P. Gingivalis IgG Titer Test for Periodontitis

Assessment of Use of Plasma or Serum IgG Test to Screen for Periodontitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01658475
Enrollment
1387
Registered
2012-08-07
Start date
2007-01-31
Completion date
2010-03-31
Last updated
2012-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

IgG titer, periodontopathic bacteria

Brief summary

This study was performed to evaluate prospectively the diagnostic utility of a blood IgG antibody titer test against periodontal pathogens.

Detailed description

Background: Periodontitis is a prevalent silent infectious disease worldwide, and affects lifestyle-related diseases such as diabetes. Therefore, efficient screening of patients is essential for general health. This study was performed to evaluate prospectively the diagnostic utility of a blood IgG antibody titer test against periodontal pathogens. Methods: Oral examination was performed and blood IgG antibody titers against periodontal pathogens were measured by ELISA, in 1387 subjects. The cut-off value of IgG titer was determined in receiver operating characteristic curve analysis, and changes in periodontal clinical parameters and IgG titers by periodontal treatment were evaluated. The relationships between IgG titers and severity of periodontitis were analyzed.

Interventions

None listed

Sponsors

Okayama University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* periodontal patients * adults

Exclusion criteria

* difficulty of communication * received periodontal therapy within 3 months * with other diseases, i.e., hypertension, diabetes (self reported)

Design outcomes

Primary

MeasureTime frameDescription
Level of IgG antibodies in serum/plasma against periodontal pathogens1 to 3 months after basic periodontal treatment (Scaling and root planing)Serum/plasma samples will be screened for the presence of IgG antibodies against the below mentioned periodontal pathogens, using the ELISA method. Aggregatibacter actinomycetemcomitans, Eikenella corrodens, Prevotella intermedius, Porphyromonas gingivalis

Secondary

MeasureTime frameDescription
Periodontal pocket depth1 to 3 months after basic periodontal treatmentClinical observation on periodontal pocket depth before and after basic periodontal treatment, in order to confirm appropriate effects of the treatment.
Bleeding on probing1 to 3 monthsafter basic periodontal treatmentJudging from bleeding from gingiva after periodontal pocket probing, degree of inflammation will be understood.
Tooth mobility1 to 3 months after basic periodontal treatmentClinical observation to understand decrease of inflammation

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026